acetylglucosamine has been researched along with Hypertrophy in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Ledee, D; Olson, AK; Olson, HM; Palazzo, T; Paša-Tolić, L; Zhou, M; Zhu, WZ | 1 |
Ashok, D; Avila, E; Foster, DB; Jung, J; Modaressanavi, A; O'Rourke, B; Papanicolaou, KN; Zachara, NE; Zhang, W | 1 |
Du, H; Han, P; Li, S; Shao, M; Song, G; Sun, H; Wang, W; Yi, T | 1 |
Chatham, JC; Cseh, J; Degrell, P; Fülöp, N; Mohás, M; Molnár, GA; Pajor, L; Wittmann, I | 1 |
Chatham, JC; Dell'Italia, LJ; Marsh, SA | 1 |
Aronsen, JM; Carlson, CR; Christensen, G; Grønning-Wang, LM; Kvaløy, H; Lunde, IG; Qvigstad, E; Sjaastad, I; Tønnessen, T | 1 |
Andrés-Bergós, J; Gómez, R; Herrero-Beaumont, G; Largo, R; Larranaga-Vera, A; Tardio, L | 1 |
Humphreys-Beher, MG | 1 |
8 other study(ies) available for acetylglucosamine and Hypertrophy
Article | Year |
---|---|
First comprehensive identification of cardiac proteins with putative increased O-GlcNAc levels during pressure overload hypertrophy.
Topics: Acetylglucosamine; Animals; Azides; Chromatography, Liquid; Hypertrophy; Mice; Protein Processing, Post-Translational; Proteins; Tandem Mass Spectrometry | 2022 |
Inhibiting O-GlcNAcylation impacts p38 and Erk1/2 signaling and perturbs cardiomyocyte hypertrophy.
Topics: Acetylglucosamine; Humans; Hypertrophy; Myocytes, Cardiac; N-Acetylglucosaminyltransferases; Phosphorylation; Proteins; Signal Transduction | 2023 |
Astragaloside IV ameliorates renal injury in db/db mice.
Topics: Acetylglucosamine; Albuminuria; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Glomerular Filtration Rate; Glycated Hemoglobin; Hypertrophy; Kidney; Lipocalin-2; Liver; Mice; Phosphorylation; Saponins; Signal Transduction; Transforming Growth Factor beta1; Triterpenes | 2016 |
Evidence of O-linked N-acetylglucosamine in diabetic nephropathy.
Topics: Acetylglucosamine; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertrophy; Immunohistochemistry; Kidney; Male; N-Acetylglucosaminyltransferases | 2009 |
Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.
Topics: Acetylglucosamine; Animals; Biosynthetic Pathways; Cells, Cultured; Diabetes Mellitus, Type 2; Gene Expression; Glycosylation; Hexosamines; Humans; Hypertrophy; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Proteins; Signal Transduction | 2011 |
Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
Topics: Acetylglucosamine; Animals; beta-N-Acetylhexosaminidases; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Glycosylation; Heart Failure; Humans; Hypertrophy; Myocardium; N-Acetylglucosaminyltransferases; Rats; Rats, Inbred Strains; RNA, Messenger; Signal Transduction | 2012 |
The increase in O-linked N-acetylglucosamine protein modification stimulates chondrogenic differentiation both in vitro and in vivo.
Topics: Acetylglucosamine; Animals; Cell Differentiation; Cell Line; Chondrocytes; Gene Expression Regulation, Enzymologic; Hypertrophy; In Vitro Techniques; Insulin; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; N-Acetylglucosaminyltransferases; Signal Transduction; Tissue Distribution | 2012 |
Restoration of alpha-lactalbumin-inhibited rat parotid salivary gland hypertrophy and hyperplasia by agents specific for membrane glycoprotein N-acetylglucosamine.
Topics: Acetylglucosamine; Animals; Cell Division; Galactosyltransferases; Glucosamine; Hyperplasia; Hypertrophy; Isoproterenol; Lactalbumin; Male; Parotid Gland; Rats; Rats, Inbred Strains | 1989 |